Curran Daniel J. has filed 6 insider transactions across 3 companies since June 2024.
Most recent transaction: a grant/award of 16833 shares of ALX ONCOLOGY HOLDINGS INC ($ALXO) on January 20, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 20, 2026 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Curran Daniel J. | Not found | A | Stock Option (right to buy) | 16833 | $0.00 | 16,833.0000 | 54,218,001 | 9999.99% | 0.03% |
| Nov. 20, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Curran Daniel J. | Director | A | Options to purchase common stock | 18115 | $0.00 | 58,115.0000 | 127,201,954 | 45.29% | 0.01% |
| Nov. 20, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Curran Daniel J. | Director | A | Restricted Stock Units | 5468 | $0.00 | 63,583.0000 | 127,201,954 | 9.41% | 0.00% |
| Aug. 12, 2025 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Curran Daniel J. | Not found | A | Stock option (right to buy) | 40400 | $0.00 | 40,400.0000 | 53,384,145 | 9999.99% | 0.08% |
| June 11, 2025 | Xilio Therapeutics, Inc. | $XLO | Curran Daniel J. | Not found | A | Stock Option (right to buy) | 31000 | $0.00 | 31,000.0000 | 63,465,063 | 9999.99% | 0.05% |
| June 14, 2024 | Xilio Therapeutics, Inc. | $XLO | Curran Daniel J. | Not found | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |